Journal News

From the journals: MCP

Latavia Hill
Sept. 25, 2020

We offer summaries of recent papers from the journal Molecular & Cellular Proteomics. Topics include how marine iguanas mark their turf, a new way to study Parkinson’s disease and glycosylation in influenza A.

 

Immune function of femoral glands in marine iguanas

Femoral glands play a key role in chemical signaling in many lizards and amphibian species, including marine iguanas. Male iguanas secrete substances from their femoral glands to attract female mates, and researchers hypothesize that certain lipids in these secretions aid in territory marking and male quality communication. Recently, Fredrick Tellkamp, Franziska Lan and a team of German researchers published a paper in the journal Molecular & Cellular Proteomics that focused on identifying the function and identity of proteins found in femoral gland secretions using a comprehensive proteomic approach.

The researchers developed the first transcriptome data set and used this information to identify various phospholipase isoforms in marine iguanas. They used prediction software to characterize unidentifiable proteins and learned that two of the 15 candidates were enriched in femoral gland secretions. Next, they used several biochemical methods, including mass spectrometry analysis, to characterize these compounds further. This analysis revealed several thousand hits, and further experimentation identified epidermis-specific proteins, lipid-binding proteins and immune-responsive proteins.

The work also yielded femoral gland proteins that have antimicrobial properties. This finding led to the generation of a library of antimicrobial peptides, and the researchers selected 17 AMPs for analysis. Of these 17 AMPs, peptide 4 showed strong antimicrobial effects againstE. coli and Bacillus subtilisin growth rate reduction experiments. The researchers speculate that AMPs and immune cells in femoral gland secretions provide protection against bacterial infection and degradation when the femoral gland opens during male iguana territory marking, which is crucial to survival.

Iguana-800x600.jpg
Helene Hoffman
Male iguanas secrete substances from their femoral glands to attract female mates.

A new way to study Parkinson’s

Parkinson’s disease is a progressive, neurodegenerative disorder that causes involuntary loss of control over some body functions. The causative agents of some Parkinson’s cases are mutations in the leucine-rich repeat kinase 2, or LRRK2. These changes lead to increased kinase activity, which enhances the phosphorylation of an important protein known as Rab10 involved in disease manifestation. Recent work published in the journal Molecular & Cellular Proteomics by Ozge Karayel of the Max Planck Institute of Biochemistry and an international team focused on determining the stoichiometry of Rab10-Thr73 in Parkinson’s patient samples.

The researchers developed a highly sensitive, mass spectrometry–based assay, mxSIM, to show that Rab10 phosphorylation is a direct readout for LRKK2 activity. Using mxSIM coupled with in-gel digestion, the researchers detected small differences in LRRK2 activity in mouse fibroblast cells. Next, they tested Rab10 levels before and after LRRK2 inhibition in both human peripheral blood and Parkinson’s patients and found increased Rab10-Thr73 phosphorylation levels in the patients as compared to healthy controls. Overall, this work provides new knowledge about the role of Rab10-Thr73 in LRRK2-associated Parkinson’s. Furthermore, these findings can aid the development of new medications that will treat disease progression, not just the symptoms. Lastly, the mxSIM technology can be used to study other diseases.

Measuring glycosylation in influenza A

Influenza A is an RNA virus that affects birds and mammals. Strains of this virus caused the 1918 Spanish flu pandemic and the more recent 2009 H1N1 swine flu outbreak. This virus has a high mutation rate, which ultimately helps it to evade the host immune response. This is why researchers create new flu vaccines annually. Influenza vaccine development takes advantage of antigenicity of the influenza A envelope protein hemagglutinin, or HA, and its glycosylation state.

Recent work published in the journal Molecular & Cellular Proteomics focused on determining if there is a difference in glycosylation at the protein level in two related influenza strains, using a statistics-based approach. Deborah Chang of Boston University and a team of U.S. researchers used the Tanimoto similarity metric and determined the hemagglutinin glycosylation similarities for the wild-type SWZ13 strain versus a SW13 mutant. The mutant strain contained the same sequons as the wild type, but at the whole glycoprotein level the two strains were measurably distinct in glycosylation due to alteration of head group glycosylation. The researchers concluded that the Tanimoto similarity metric is useful for determining alterations in glycoprotein glycosylation from bottom-up glycoproteomics data.  This work will aid future vaccine production.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Latavia Hill

Latavia Hill is a graduate student studying microbiology at the University of Kansas.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Engineering cells to broadcast their behavior can help scientists study their inner workings
News

Engineering cells to broadcast their behavior can help scientists study their inner workings

July 20, 2024

Researchers can use waves to transmit signals from the invisible processes and dynamics underlying how cells make decisions.

From the journals: JBC
Journal News

From the journals: JBC

July 19, 2024

Lung cancer cells resist ferroptosis. ORMDL3 in ulcerative colitis. Novel genetic variants in thyroid cancer. Read about these recent papers.

Seeking the sweet spot to beat a pig parasite
Journal News

Seeking the sweet spot to beat a pig parasite

July 16, 2024

Researchers extracted, separated and tested glycans from the porcine whipworm in an effort to determine the best way to develop treatments and vaccines.

Radioactive drugs strike cancer with precision
News

Radioactive drugs strike cancer with precision

July 14, 2024

The tumor-seeking radiopharmaceuticals are charting a new course in oncology, with promise for targeted treatments with fewer side effects.

Animals have used bioluminescence to communicate for millions of years
News

Animals have used bioluminescence to communicate for millions of years

July 13, 2024

Despite its widespread occurrence, scientists don’t yet know when or where this phenomenon first emerged, or its original function.

Getting to the genetic basis of cardiovascular disease
Journal News

Getting to the genetic basis of cardiovascular disease

July 11, 2024

Edwin G. Peña Martínez received a JBC Tabor award for associating the condition with mutations in noncoding sequences.